Am J Health Syst Pharm. 2010;67(10):806-809. The patient had no signs or symptoms of retroperitoneal hematoma until she became acutely hypotensive approximately 48 hours after the administration of ...

Apotex recalled two batches of mislabeled enoxaparin sodium syringes Enoxaparin is used to prevent blood clots It should not be stopped without doctors' advice A pharmaceutical company is recalling ...

A more selective risk-stratified approach to postpartum enoxaparin (Lovenox) thromboprophylaxis for venous thromboembolism (VTE) was linked to reduced rates of wound hematomas without increasing the ...

Post transplantation restenosis, vaso-occlusion complications, and rejection contribute to the increased mortality of patients that undergo cardiac transplantation. The post-transplantation use of ...

The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis (DVT), a ...

SILVER SPRING, Md. The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected drug used to treat deep vein thrombosis, the agency said Friday. The FDA ...

The FDA has granted approval to Amphastar's generic version of Lovenox (enoxaparin sodium), Watson Pharmaceuticals has announced. The low molecular weight heparin will be sold by Watson under an ...

A total of 15 pregnant subjects on therapeutic doses of enoxaparin (1 mg/kg ±20% subcutaneously (s.c.) twice daily (b.i.d.)) were enrolled prospectively in this cross-sectional pilot project. Three ...

LANGHORNE, Pa.--(BUSINESS WIRE)--#Enoxaparin--Techdow USA Inc. (“Techdow USA”), a growing market leader and vertically integrated generic injectables company, today announced the launch of its 30mg, ...

Purpose. A case of fatal retroperitoneal hematoma that developed after enoxaparin administration in a woman with paroxysmal atrial flutter and chest pain is reported. Summary. A 63-year-old, 74-kg, ...